Bambusa Therapeutics Stock (NASDAQ:BBTX)
Previous Close
$16.00
52W Range
$13.60 - $17.42
50D Avg
$15.66
200D Avg
$15.66
Market Cap
$799.67M
Avg Vol (3M)
$969.70K
Beta
-
Div Yield
-
BBTX Company Profile
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.